BioMarin Pharmaceutical, Inc. (BMRN)
64.08
+0.66
(+1.04%)
USD |
NASDAQ |
Feb 20, 16:00
64.00
-0.08
(-0.12%)
After-Hours: 20:00
BioMarin Pharmaceutical SG&A Expense (Quarterly) : 268.40M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 117.08M |
| Gilead Sciences, Inc. | 1.794B |
| Merck & Co., Inc. | 2.898B |
| AbbVie, Inc. | 3.895B |
| Bristol Myers Squibb Co. | 2.181B |